This pathological hyperactivity prompts midkine (MDK) [523]—a heparin‐binding growth factor—to stimulate T lymphocyte CCL4 secretion, triggering subsequent microglial CCL5 release; a pivotal mitogenic stimulus for glioma proliferation [524]. The gene discussed is MDK; the disease is central nervous system cancer.